Navigation Links
HTI-501 Data Support Commencement of Phase 2 Portion of Clinical Trial
Date:1/31/2012

yme.com/">www.halozyme.com.

Safe Harbor Statement

In addition to historical information, the statements set forth above include forward-looking statements including without limitation our future development plans for HTI-501, anticipated study design and patient enrollment targets for the remainder of the Phase 1 study and future Phase 2 trial for HTI-501.  These forward-looking statements involve risk and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. The forward-looking statements are also identified through use of the words "believe," "enable," "may," "will," "could," "intends," "estimate," "anticipate," "plan," "predict," "probable," "potential," "possible," "should," "continue," and other words of similar meaning. Actual results could differ materially from the expectations contained in forward-looking statements as a result of several factors, including clinical trial results, delays in development, possible adverse events associated with the use of the product candidate, regulatory approval requirements and competitive conditions. These and other risk factors that may result in differences are discussed in greater detail in the Company's reports on Forms 10-K, 10-Q, and other filings with the Securities and Exchange Commission.

Media/Investor Contact:
Anne Erickson
Executive Director
Halozyme Therapeutics
858-704-8264
aerickson@halozyme.com


'/>"/>
SOURCE Halozyme Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. New Study Supports Efficacy of Vagus Nerve Stimulation for Treatment-Resistant Depression
2. Cell Therapeutics, Inc. (CTI) Supports Panel Discussion on Women and Lung Cancer on Capitol Hill
3. EntreMed Raises $20 Million to Support Clinical Development Program
4. Interim Response and Safety Analyses Support Continuation of Allos Therapeutics Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-Cell Lymphoma
5. Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports use as a Single Agent in Patients with Advanced Colorectal Cancer
6. Isis Reports Preclinical Data Supporting Liver Safety of ISIS 301012
7. PDHI Launches ConXus Rewards, Announces Partnership With Hallmark Insights to Support Incentive-Driven Wellness Programs
8. PositiveFriends.com Launches STD Social Networking Site Balancing Dating with Online Support Features
9. Data Support use of SuperGens CLIMB Technology in Lead Development and Optimization
10. SAIC Awarded Malaria Vaccine Production Support Contract Extension by the National Institute of Allergy and Infectious Diseases
11. Consumer Advocates Support Patent Office on Stem Cell Patent Rejection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... PARK, Calif. , Sept. 3, 2015 ... device company that is providing innovative evidence-based solutions for ... management will be presenting at the Morgan Stanley Global ... York City.  Nevro management is scheduled ... be accessible via a live audio webcast, accessible in ...
(Date:9/3/2015)... , Sept. 3, 2015  Ascendis Pharma ... stage biotechnology company that applies its innovative ... needs, today announced plans to present at ... Fargo Healthcare Conference in BostonDate: , Thursday, ... Bank of America Merrill Lynch Global Healthcare ...
(Date:9/3/2015)...  As part of its ongoing commitment to provide ... R. Katz , MD, MPH, cardiac surgeon and chief ... Institute implanted the first HeartMate 3 left ventricular assist ... as part of the prestigious MOMENTUM 3™ Clinical Trial. ... the United States—and the first in central Virginia—chosen to ...
Breaking Medicine Technology:Ascendis Pharma A/S to Present at Three Upcoming Investor Conferences 2Bon Secours' Patient FIRST in Central Virginia to receive New Life-saving Care 2Bon Secours' Patient FIRST in Central Virginia to receive New Life-saving Care 3Bon Secours' Patient FIRST in Central Virginia to receive New Life-saving Care 4
(Date:9/4/2015)... ... ... Many consumers are looking for a quick and convenient way to produce a hot remedy ... Cups provide a quick and simple way to brew a hot cup of cold remedy ... a result, they enhance comfort and health. The invention features a novel design that is ...
(Date:9/4/2015)... ... September 04, 2015 , ... ECC announces the ... created specifically for adults with intellectual, developmental and acquired disabilities. The first community, ... 30 cottage or “pocket” homes. In this community, adults will live safely and ...
(Date:9/4/2015)... ... September 04, 2015 , ... FiltersFast.com, ... Day offer that cannot be passed up. FiltersFast.com, will ship all orders ... and water filtration product replacements. Take advantage of this promotion now through September ...
(Date:9/3/2015)... ... 2015 , ... Allied Anesthesia is proud to announce a continuing partnership with ... exception. , St. Jude was recently named one of the nation’s top stroke centers ... of only 10 hospitals in the state to earn the distinction. , The ...
(Date:9/3/2015)... NH (PRWEB) , ... September 03, 2015 , ... ... new agreement with Amerinet Inc., a leading national healthcare solutions organization, to provide ... Epic EMR. , Through this agreement, Amerinet members will receive negotiated pricing on ...
Breaking Medicine News(10 mins):Health News:Redesigned Packaging for Powdered Medicinal Mix Invented by InventHelp® Client (CBA-2637) 2Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 2Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 3Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 4Health News:FiltersFast.com Wows with a Long Labor Day Weekend Shipping Offer 2Health News:Allied Anesthesia Physicians Announce Partnership with St. Jude 2Health News:Allied Anesthesia Physicians Announce Partnership with St. Jude 3Health News:E-Volve Health to Offer EMR Consulting Solutions to Amerinet Members 2
... for Increased Awareness of Disease, Funding for Research, SAN ... of 40,000 people in the U.S. who will lose,their lives ... will die from breast cancer. Yet, most people have never ... has no FDA approved treatment, no known cause and no ...
... BENSALEM, Pa., Oct. 31 Law Offices of Howard ... been filed on behalf,of purchasers of the common stock ... WCG ) between May 8, 2006 and October,24, 2007, ... in the United States District Court for the Middle ...
... Group Uses PETA Talking Points, Discourages Donations to,Legitimate ... health reporters,cover today,s report on global causes of ... nonprofit Center for Consumer Freedom is urging,them to ... animal,rights group calling itself "The Cancer Project." A ...
... Insurers Outline Features of their Countries, Models at,Event Sponsored ... Switzerland and The,Netherlands are among countries in Europe ... private sector plays a central role,in making care better ... countries have taken to cover all of their citizens, ...
... their risk of dying of the disease in half ... their cancer, compared to those who dont receive active ... diagnosed with localized prostate cancer, according to a study ... Therapeutic Radiology and Oncologys 49th Annual Meeting in Los ...
... says exercise and diet can lower chances of malignancies ... exercise and proper nutrition are key to reducing your ... adopt these practices, the better off you,ll be, a ... childbearing, breast-feeding, and adult height and weight also influence ...
Cached Medicine News:Health News:Goulet's Life Lost to Untreatable Lung Disease That Claims as Many Lives as Breast Cancer Each Year 2Health News:Consumer Alert: 'Cancer Project' Organization Is a Deceptive Animal Rights Group 2Health News:Forum Highlights Role of Private Sector in Achieving Universal Health Coverage in Europe 2Health News:Forum Highlights Role of Private Sector in Achieving Universal Health Coverage in Europe 3Health News:Radiation seed implant decreases risk of death over watchful waiting 2Health News:Obesity Linked to Increased Cancer Risk 2Health News:Obesity Linked to Increased Cancer Risk 3
For in vitro diagnostic use,with the IMMULITE 2000 Analyzer for,the quantitative measurement of prostatic,acid phosphatase (PAP) in serum, as an,aid in patient management....
For the quantitative measurement of human prostatic acid phosphatase (PAP) in human serum....
... Quality EEG recording is assured even in ... has high performance, high sensitivity amplifiers, ... rejection filter, shielded electrodes and a high ... Neurofax is a complete and ready ...
... MagPro is the high performance magnetic stimulator ... in medical research. , ,MagPro is able to ... precise studies of the field/nerve interface can be ... biphasic waveform and coil-current direction. , , , ...
Medicine Products: